Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evaluation of [18F]GATT-44 for PET Imaging of GAT-1
NCT07457736Phase 1Recruiting
- Sponsor
- Yale University
- Start
- Jan 2026
- Primary completion
- Jan 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of [18F]GATT-44 (3 arms), sponsored by Yale University. Primary endpoints: Test-Retest reproducibility calculations, Specific binding levels of [18F]GATT44 and 1 more. Started Jan 2026; status: recruiting.
02
Drugs
[18F]GATT-44
Beyond the preview
Go deeper on NCT07457736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07457736.